ANTIPLATELET DRUGS

Clinical trials for ANTIPLATELET DRUGS explained in plain language.

Never miss a new study

Get alerted when new ANTIPLATELET DRUGS trials appear

Sign up with your email to follow new studies for ANTIPLATELET DRUGS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Heart stent safety showdown: new drug combo vs. standard care for seniors

Disease control Recruiting now

This study aims to find the safest and most effective blood-thinning drug combination for people over 65 who receive a heart stent after a heart attack or severe chest pain. It will compare a newer drug (indobufen) with the standard drug (aspirin), both taken with a second medica…

Matched conditions: ANTIPLATELET DRUGS

Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

ANTIPLATELET DRUGS

Get alerted when new ANTIPLATELET DRUGS trials appear

Heart stent safety showdown: new drug combo vs. standard care for seniors